A comparatiVe Study on Efficacy and Safety of Lipegfilgrastim in Comparison to Pegfilgrastim in Elderly Patients With Aggressive B Cell Non-HOdgkin Lymphomas at hIgh Risk for R-CHOP-21-inDuced Neutropenia
Clinical trial NCT02044276 · COMPLETED
Trial details
- NCT number
- NCT02044276
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-31
- Primary completion
- 2017-08-29
- Enrollment
- 101
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.